Newsbenzinga
MDxHealth Says Well-Positioned to 'Return to Positive EBITDA'
· Published
Article summary
MDxHealth reports Q2 sales growth, mixed earnings and reaffirmed 2026 revenue guidance as tissue test volumes rise.
An excerpt from the original article.
Comments —
Loading comments…